Companion animal health market seen doubling by 2032

By AI, Created 4:31 AM UTC, May 29, 2026, /AGP/ – Global spending on pet care products and veterinary services is rising as owners treat animals more like family, driving demand for diagnostics, vaccines, pharmaceuticals and telemedicine. A new market analysis says the sector was worth $26.48 billion in 2025 and could reach $51.48 billion by 2032.

Why it matters: - Companion animal health is moving from a niche veterinary category to a broader pet-care market tied to preventive medicine, chronic disease management and digital care tools. - The shift affects pharmaceutical companies, clinics, insurers and e-commerce sellers as pet owners spend more on diagnostics, treatment and wellness products. - The market’s projected growth points to rising demand across both developed and emerging economies.

What happened: - A new market analysis valued the global companion animal health market at $26.48 billion in 2025. - The analysis projects the market will grow at a 9.87% compound annual growth rate from 2026 to 2032. - The market is expected to reach nearly $51.48 billion by 2032. - The report covers products and services for dogs, cats, horses and exotic pets. - The company offers a sample of the report and access to the full report.

The details: - The market includes pharmaceuticals, vaccines, diagnostics, nutritional supplements, veterinary services and advanced treatment solutions. - Rising pet adoption, more awareness of animal healthcare and rapid technology adoption are driving the sector. - Pet humanization and higher disposable incomes are lifting spending on preventive veterinary care. - Preventive care demand is rising for vaccinations, diagnostic screenings, parasite control and nutrition management. - The COVID-19 pandemic accelerated pet adoption, creating a larger base of long-term veterinary spending. - Artificial intelligence, telemedicine, wearable monitoring devices and advanced imaging are changing diagnosis and treatment. - Veterinary diagnostics firms are investing in molecular diagnostics, point-of-care testing and digital imaging systems. - Cloud-based practice software is streamlining medical records, scheduling and remote consultations. - Tele-veterinary services are gaining traction in rural and underserved areas. - New pharmaceuticals and biologics are being developed for chronic diseases, pain management, dermatology and infectious diseases. - Pharmaceuticals currently hold the largest share, supported by chronic disease and infection treatment needs. - Anti-parasitic drugs, anti-inflammatory medicines, antibiotics and pain treatments make up a major part of sales. - Vaccines are growing as disease-prevention awareness rises and government vaccination programs expand. - Zoonotic disease concerns are also supporting vaccine demand. - Diagnostics are projected to grow quickly as imaging, molecular testing and lab technologies improve. - Dogs are the largest animal segment because of high adoption rates and higher spending on care. - Cats are a fast-growing segment as urban ownership rises and feline health awareness improves. - Equine health continues to expand, supported by sports medicine, orthopedic treatment and performance-focused care. - Veterinary hospitals and clinics remain the largest distribution channel. - E-commerce is growing quickly as pet owners buy medications, supplements, pet food and health products online.

Between the lines: - The market is being shaped by a broader consumer mindset that treats pets as family members, not just animals. - Insurance penetration is making expensive procedures, surgeries and chronic care more accessible to pet owners. - Personalized veterinary medicine could become a major differentiator if genetic testing and precision treatment scale. - Wearable pet devices such as smart collars and health trackers may create new recurring revenue streams through early detection and monitoring. - Asia-Pacific and Latin America stand out as underpenetrated regions with room for faster adoption. - North America remains the largest market because of pet ownership, spending and veterinary infrastructure. - Europe holds a significant share, helped by animal welfare regulation. - Competition is intensifying as companies pursue mergers, partnerships, product launches and digital tools. - Sustainability is becoming part of product strategy, with more interest in organic supplements, plant-based nutrition and eco-friendly packaging.

What’s next: - Veterinary companies are likely to keep investing in vaccines, biologics, diagnostics, telemedicine and precision medicine. - Growth through 2032 will likely depend on how quickly providers expand access to preventive care and advanced treatment. - Emerging technologies and rising pet spending in Asia-Pacific and Latin America could drive the next wave of expansion. - Companies that combine technology, personalized care and accessible service are positioned to gain share.

The bottom line: - Companion animal health is becoming a larger, more technology-driven care market as pet ownership rises and owners spend more on prevention, treatment and convenience.